Eszopiclone
- Product NDC
- 53217-150
- 11-digit product format
- 532170150
- Labeler code
- 53217
- Product ID
- 53217-150_da945963-e887-4560-9951-93ec1552cb45
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Eszopiclone
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Aidarex Pharmaceuticals LLC
- Application
- ANDA091166
- Marketing category
- ANDA
- Marketing start
- 2014-04-15
- Marketing end
- 0000-00-00
- Substance
- ESZOPICLONE
- Active strength
- 1 mg/1
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 53217-150 | I | Inactivated by FDA | 2026-08-03 | ||
| excluded package | package | 53217-150 | 53217-150-30 | I | Inactivated by FDA | 2026-08-03 |
Observed NDC auxiliary status history#
Observed captured status history: Rows come only from successfully parsed FDA auxiliary ZIP captures. They show the state present in that artifact, not a continuous regulatory timeline. Absence before, after, or between captures is not proof of status, and a known non-data HTTP 403 capture is preserved in backfill provenance but cannot produce a status row.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 53217-150 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 8dfbde2a14a4… | c9ff85d89658… | ||
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 53217-150 | 53217-150-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 8dfbde2a14a4… | c9ff85d89658… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | 53217-150 | I | Inactivated by FDA | excluded / ndc_excluded.zip | e2bbac7714bc… | 27bdfed8d636… | ||
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 53217-150 | 53217-150-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | 53217-150 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 9bebd1f3094a… | 5416666fcb17… | ||
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 53217-150 | 53217-150-30 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 9bebd1f3094a… | 5416666fcb17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091166-001 | ESZOPICLONE | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2014-04-15 | |
| A091166-002 | ESZOPICLONE | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2014-04-15 | |
| A091166-003 | ESZOPICLONE | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2014-04-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A091166-001 | AB |
| A091166-002 | AB |
| A091166-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A091166-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2014-04-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A091166-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2014-04-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A091166-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2014-04-15 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091166-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2014-04-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091166-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2014-04-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091166-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2014-04-15 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091166-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2014-04-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091166-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2014-04-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091166-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2014-04-15 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091166-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2014-04-15 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091166-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2014-04-15 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091166-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2014-04-15 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091166-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2014-04-15 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091166-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2014-04-15 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091166-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2014-04-15 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091166-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2014-04-15 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091166-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2014-04-15 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091166-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2014-04-15 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091166-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2014-04-15 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091166-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2014-04-15 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091166-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2014-04-15 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091166-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2014-04-15 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091166-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2014-04-15 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091166-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2014-04-15 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091166-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2014-04-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091166-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2014-04-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091166-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2014-04-15 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091166-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2014-04-15 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091166-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2014-04-15 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091166-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2014-04-15 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091166-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2014-04-15 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091166-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2014-04-15 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091166-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2014-04-15 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091166-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2014-04-15 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091166-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2014-04-15 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091166-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2014-04-15 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091166-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2014-04-15 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091166-002 | ESZOPICLONE | 2MG | TABLET / ORAL | AB | 2014-04-15 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091166-003 | ESZOPICLONE | 3MG | TABLET / ORAL | AB | 2014-04-15 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A091166-001 | ESZOPICLONE | 1MG | TABLET / ORAL | AB | 2014-04-15 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A091166-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A091166-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A091166-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091166-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091166-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091166-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A091166-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A091166-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A091166-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091166-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091166-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091166-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091166-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091166-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091166-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091166-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091166-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091166-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091166-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091166-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091166-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091166-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091166-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091166-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091166-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091166-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091166-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A091166-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A091166-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A091166-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091166-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091166-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091166-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091166-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091166-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091166-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091166-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091166-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091166-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A091166-001 | AB | 1 | 8072bd15b7f6… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eszopiclone | ESZOPICLONE | St Mary's Medical Park Pharmacy | c4ff1d6a-918e-c046-e053-2a95a90a9c9b | 2026-06-20 | Boxed warning, Warnings, Adverse reactions | 091166 ANDA091166 |
| Eszopiclone | ESZOPICLONE | Bryant Ranch Prepack | e04d4f8b-c9a1-4dc9-aac4-2e6376cd9a0c | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 091166 ANDA091166 |
| Eszopiclone | ESZOPICLONE | Preferred Pharmaceuticals Inc. | 0102ea59-77b1-4e74-83ec-1d205563b55f | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | 091166 ANDA091166 |
| Eszopiclone | ESZOPICLONE | NuCare Pharmaceuticals,Inc. | c24ec179-f869-746f-e053-2995a90aa1ff | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 091166 ANDA091166 |
| Eszopiclone | ESZOPICLONE | Asclemed USA, Inc. | 838559f7-4b69-4831-bf50-ab37c6c24c2b | 2026-03-10 | Boxed warning, Warnings, Adverse reactions | 091166 ANDA091166 |
| Eszopiclone | ESZOPICLONE | Glenmark Pharmaceuticals Inc. USA | 584dc66c-063a-4552-a056-74b811e2bc80 | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | 091166 ANDA091166 |
| Eszopiclone | ESZOPICLONE | Bryant Ranch Prepack | d1baa5ba-73ac-462b-a728-217d5992674a | 2024-08-23 | Boxed warning, Warnings, Adverse reactions | 091166 ANDA091166 |
| Eszopiclone | ESZOPICLONE | Advanced Rx of Tennessee, LLC | 1baa56e5-34d5-c8a1-e063-6394a90ae6c7 | 2024-06-24 | Boxed warning, Warnings, Adverse reactions | 091166 ANDA091166 |
| Eszopiclone | ESZOPICLONE | Proficient Rx LP | e32746a8-6440-4b0a-a445-4467cf0329d5 | 2024-02-01 | Boxed warning, Warnings, Adverse reactions | 091166 ANDA091166 |
| Eszopiclone | ESZOPICLONE | Proficient Rx LP | ac996f97-fd92-44f8-8bb5-478a81ffb33d | 2022-07-01 | Boxed warning, Warnings, Adverse reactions | 091166 ANDA091166 |
| Eszopiclone | ESZOPICLONE | Proficient Rx LP | edc03482-b013-448a-8cd9-2a17bd6d15e9 | 2022-05-01 | Boxed warning, Warnings, Adverse reactions | 091166 ANDA091166 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f65008ed-f925-2246-581a-e6a3201df7e4 | Product name | 5 | 20250107 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53217-150-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2842-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use eszopiclone tablets safely and effectively. See full prescribing information for eszopiclone tablets . Eszopiclone Tablets, for oral use, CIV Initial U.S. Approval: 2004 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53217-150-30 | Eszopiclone | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 53217-150-30 | EA - Each | 53217-150 | 8530b41a-b478-493c-af91-9338a18b8caa | 1 | 2017-03-06 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 485440 | eszopiclone 1 MG Oral Tablet | PSN | 397a8650-84fa-43ef-9006-922a39bc0b1d | 1 |
| 485440 | eszopiclone 1 MG Oral Tablet | SCD | 397a8650-84fa-43ef-9006-922a39bc0b1d | 1 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 53217-150-30 | 53217015030 | 30 in 1 BOTTLE | Historical |